Coagulation in the equine intensive-care patient

Clinical Techniques in Equine Practice

Volumn 2, Issue 2, 2003, Pages 178-187

  Byars, T D ^a   Davis, Debra ^c   Divers, T J ^b  

^a HAGYARD EQUINE MEDICAL INSTITUTE   (United States)

^b Department of Clinical Sciences   (United States)

^c NONE

Author keywords

Disseminated intravascular coagulation; Hemorrhage; Laminitis; Phlebitis; Thrombocytopenia; Thrombosis

Indexed keywords

EQUIDAE; EQUUS CABALLUS;

EID: 23744446566     PISSN: 15347516     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1534-7516(03)00014-3     Document Type: Article

References (47)

1. Bell WN, et al: The coagulation mechanism of the blood of the horse with particular reference to its "hemophiliod" status. J Comp Pathol 65:255-261, 1955
2. Sjolin KE: Coagulation defect in horse plasma. Proc Soc Exp Biol Med 94:818-820, 1957
3. st Intl Symp Equine Hemat AAEP 00:202-205, 1975
4. nd ed. American Veterinary Publishers, Wheaton, IL, 1972, pp 358-362
5. Kopp K, et al: Bleeding time effects of three non-steroidal antiflammatory drugs in the horse. Equine Vet J 17:322-324, 1985
6. rd ed. St. Louis, Mosby, 2002, pp 97-101
7. th IVECCS, San Antonio, TX, 2002, pp 625-629, 2002
8. Hay KL, Bull B: Rapid-SF: a rapid whole-blood screen for soluble fibrin monomer. Throm Hemo 88:773-780, 2002
9. Sprayberry KA: Hemorrhage and hemorrhagic shock. Bluegrass Equine Medicine and Critical Care Symposium, Lexington, KY, Oct. 2001
10. Brianceau P, Divers TJ: Acute thrombosis of limb arteries in horses with sepsis: five cases (1988-1998). Equine Vet J 33:105-109, 2001
11. Byars TD: Critical care bleeding and coagulopathies in the horse. Bluegrass Equine Medicine and Critical Care Symposium, Lexington, KY, Oct. 2001
12. Kopp KJ, Moore JN, Byars TD, et al: Template bleeding time and thromboxane generation in the horse: effects of three non-steroidal anti-inflammatory drugs. Equine Vet J 17:322-324, 1985
13. Davis EG, Wilkerson MJ, Rush BR: Flow cytometry: clinical applications in equine medicine. J Vet Intern Med 16:404-410, 2002
14. Hinchcliff KW, Kociba GJ, Mitten LA: Diagnosis of EDTA-dependent pseudothrombocytopenia in a horse. J Am Vet Med Assoc 203:1715-1716, 1993
15. Monreal L, Angles A, Espada Y, et al: Hypercoagulation and hypofibrinolysis in horses with colic and DIG. Equine Vet 32:19-25, 2000 (suppl)
16. Sandholm M, Vidovic A, Puotunen-Reinert A, et al: D-dimer improves the prognostic value of combined clinical and laboratory data in equine gastrointestinal colic. Acta Vet Scand 36:255-272, 1995
17. Epstein FH: Vascular bed specific hemostasis and the hypercoagulation states. New Engl J Med 340:1555-1563, 1999
18. Gardner SY, Reef VB, Spencer PA: Ultrasonographic evaluation of horses with thrombophlebitis of the jugular vein: 46 cases (1985-1988). J Am Vet Med Assoc 199:370-373, 1991
19. Traub-Dargata JL, Dargatz DAA: Retrospective study of vein thrombosis in horses treated with intravenous fluids in a veterinary teaching hospital. J Vet Intern Med 8:264-266, 1994
20. Vaneechoutte M, Devriese LA, Kijkshoorn L, et al: Acinetobacter baumannii-infected vascular catheters collected from horses in an equine clinic. J Clin Microbiol 38:4280-4281, 2000
21. Orsini JA, Kreuder C: Blood collection, in Orsini JA, Divers TJ (eds): Manual of Equine Emergencies, 2nd ed. Philadelphia, PA, WB Saunders, 2003, pp 3-5
22. Peterson FY, Kirchhoff KT: Analysis of the research about heparinized versus nonheparinized intravascular lines. Heart Lung 20:631-640, 1991
23. Schultz AA, Drew D, Hewitt H: Comparison of normal saline and heparinized saline for patency of IV locks in neonates. Appl Nurs Res 15:28-34, 2002
24. Cambridge H, Lees P, Hooke RE, et al: Antithrombotic actions of aspirin in the horse. Equine Vet 23:123-127, 1991
25. Jarvis GE, Evans RJ: Platelet-activating factor and not thromboxane A2 is an important mediator of endotoxin-induced platelet aggregation in equine heparinised whole blood in vitro. Blood Coagul Fibri nolysis 7:194-198, 1996
26. Tagalakis V, Kahn SR, Libman M, et al: The epidemiology of peripheral vein infusion thrombophlebitis: a critical review. Am J Med 113:146-151, 2002
27. Walder B, Pittet D, Tramer MR: Prevention of bloodstream infections with central venous catheters treated with anti-infective agents depends on catheter type and insertion time: evidence from a meta-analysis. Infect Control Hosp Epidemiol 23:748-756, 2002
28. Hood DM: Digital perfusion in developmental and acute laminitis. 1st International Equine Conference on Laminitis, Palm Beach, FL, February 2001, pp 33-35
29. Pollitt C: Vascular component/basement membrane pathophysiology. 1st International Equine Conference on Laminitis, Palm Beach, FL, February 2001, pp 35-57
30. Allen D Jr, Clark ES, Moore JN, et al: Evaluation of equine digital Starling forces and hemodynamics during early laminitis. Am J Vet Res 51:1930-1934, 1990
31. Hinckely KA, Fearn S, Howard BR, et al: Glyceryl trinitrate enhances nitric oxide mediated perfusion within the equine hoof. J Endocrinol 151:R1-R8, 1996
32. Rodgerson DH, Belknap JK, Moore JN, et al: Investigation of mRNA expression of tumor necrosis factor-á interleukin-1β, and clclooxygenase-2 in cultured equine digit artery smooth muscle cells after exposure to endotoxin. Am J Vet Res 62:1957-1963, 2001
33. Weiss DJ, Evanson OA: Evaluation of lipopolysaccharide-induced activation of equine neutrophils. Am J Vet Res 63:811-815, 2002
34. Weiss DJ, Evanson OA, McClenahan D, et al: Effect of a competitive inhibitor of platelet aggregation on experimentally induced laminitis in ponies. Am J Vet Res 59:814-817, 1998
35. Weiss DJ, Geor RJ, Johnston G, et al: Microvascular thrombosis associated with onset of acute laminitis in ponies. Am J Vet Res 55:606-612, 1994
36. Fontaine GL, Belknap JK, Allen D, et al: Expression of interleukin-1β in the digital laminae of horses in the prodromal stage of experimentally induced laminitis. Am J Vet Res 62:714-720, 2001
37. Winchell WS, Hardy J, Levine DM, et al: Effect of administration of a phospholipids emulsion on the initial response of horses administered endotoxin. 63:1370-1378, 2002
38. Mungall BA, Pollitt CC: Thermolysin activates equine lamellar hoof matrix metalloproteinases. J Comp Pathol 126:9-16, 2002
39. Johnson PJ, Tyagi SC, Katwa LC, et al: Activation of extracellular matrix metalloproteinases in equine laminitis. Vet Rec 142:392-396, 1998
40. Mannucci PM: Hemostatic drugs. New Engl J Med 339: 245-253, 1998
41. Matsumoto Y, et al: Carbazochrome sodium sulphonate decreases the accumulation of tissue-type plasminogen activator in culture medium of human umbilical vein endothelial cells. Blood Coag Fib 6:233-238, 1995
42. Levi M, Ten Cate H: Disseminated intravascular coagulation. New Engl J Med 341: 8:586-592, 1999
43. Dolente BA, Wilkins PA, Boston RC: Clinicopathologic evidence of disseminated intravascular coagulation in horses with acute colitis. JAVMA 220:1034-1038, 2002
44. Scharzwald CC, et al: Comparison of pharmacokinetic variables for two low-molecular weight heparins after subcutaneous administration of a single dose to horses. AJVR 63:868-873, 2002
45. Asakura H, et al: An enhanced fibrinolysis prevents the development of multiple organ failure in disseminated intravascular coagulation in spite of much activation of blood coagulation. Crit Care Med 29:1164-1169, 2001
46. Bernard GR, et al: Efficacy and safety of recombinant human activated protein c for severe sepsis. New Engl J Med 344:699-701, 2001
47. Faust SN, et al: Dysfunction of endothelical protein c activation in severe meningococcal sepsis. New Engl J Med 345:408-416, 2001